Comparison of Two Lateral Flow Immunochromatographic Assays for Rapid Detection of KPC, NDM, IMP, VIM and OXA-48 Carbapenemases in Gram-Negatives
13
9
Multidisciplinary Digital Publishing Institute (MDPI)
2140
Maimónides Biomedical Research Institute of Córdoba, Córdoba, 14004, Spain; Reina Sofía University Hospital, Córdoba, 14004, Spain; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III (ISCIII), Madrid, 28029, Spain; Team ‘Resist’ UMR1184 Immunology of Viral, Auto-Immune, Hematological and Bacterial Diseases (IMVA-HB), INSERM, Faculty of Medicine, Université Paris-Saclay, CEA, IO Healthi, Le Kremlin-Bicêtre, 94270, France; Bacteriology-Hygiene Unit, Bicêtre Hospital, Assistance Publique-Hôpitaux de Paris, Le Kremlin-Bicêtre, 94270, France; Department of Laboratory Medicine, Faculty of Applied Medical Sciences, Al Azhar University, Gaza, P600, Palestine; Médicaments et Technologies Pour la Santé (MTS), Université Paris-Saclay, CEA, INRAE, SPI, Gif-sur-Yvette, 91191, France; French National Reference Center for Antimicrobial Resistance, Le Kremlin-Bicêtre, 94270, France
Dominguez C.M., Maimónides Biomedical Research Institute of Córdoba, Córdoba, 14004, Spain, Reina Sofía University Hospital, Córdoba, 14004, Spain, CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III (ISCIII), Madrid, 28029, Spain; Oueslati S., Team ‘Resist’ UMR1184 Immunology of Viral, Auto-Immune, Hematological and Bacterial Diseases (IMVA-HB), INSERM, Faculty of Medicine, Université Paris-Saclay, CEA, IO Healthi, Le Kremlin-Bicêtre, 94270, France, Bacteriology-Hygiene Unit, Bicêtre Hospital, Assistance Publique-Hôpitaux de Paris, Le Kremlin-Bicêtre, 94270, France; Al Laham N., Team ‘Resist’ UMR1184 Immunology of Viral, Auto-Immune, Hematological and Bacterial Diseases (IMVA-HB), INSERM, Faculty of Medicine, Université Paris-Saclay, CEA, IO Healthi, Le Kremlin-Bicêtre, 94270, France, Department of Laboratory Medicine, Faculty of Applied Medical Sciences, Al Azhar University, Gaza, P600, Palestine; Nermont R., Team ‘Resist’ UMR1184 Immunology of Viral, Auto-Immune, Hematological and Bacterial Diseases (IMVA-HB), INSERM, Faculty of Medicine, Université Paris-Saclay, CEA, IO Healthi, Le Kremlin-Bicêtre, 94270, France; Volland H., Médicaments et Technologies Pour la Santé (MTS), Université Paris-Saclay, CEA, INRAE, SPI, Gif-sur-Yvette, 91191, France; Naas T., Team ‘Resist’ UMR1184 Immunology of Viral, Auto-Immune, Hematological and Bacterial Diseases (IMVA-HB), INSERM, Faculty of Medicine, Université Paris-Saclay, CEA, IO Healthi, Le Kremlin-Bicêtre, 94270, France, Bacteriology-Hygiene Unit, Bicêtre Hospital, Assistance Publique-Hôpitaux de Paris, Le Kremlin-Bicêtre, 94270, France, French National Reference Center for Antimicrobial Resistance, Le Kremlin-Bicêtre, 94270, France
T. Naas; Team ‘Resist’ UMR1184 Immunology of Viral, Auto-Immune, Hematological and Bacterial Diseases (IMVA-HB), INSERM, Faculty of Medicine, Université Paris-Saclay, CEA, IO Healthi, Le Kremlin-Bicêtre, 94270, France; email: thierry.naas@aphp.fr